Tumor therapy with biologically active anti-tumor antibodies

Details Tumor therapy with biologically active anti-tumor antibodies Tumor therapy with biologically active anti-tumor antibodies

1990-01-30

1992-02-25

Kepplinger, Esther L.

Drug, bio-affecting and body treating compositions

Lymphokine

424 8591, 424 88, 530387, 530388, 530389, 530391, 530808, 530828, 43524027, 514 2, 514 8, 514 21, A61K 39395, C07K 1528

Patent

active

050911783

ABSTRACT:
A method for identifying and using antibodies which are directed against tumor-associated glycolipid antigens and which are capable of activating serum complement or antibody dependent cellular cytotoxicity. These antibodies find use in the therapy of tumors. Administration of the antibodies results in lysis of the tumor cells in vivo.

REFERENCES:
patent: 4146603 (1979-03-01), Davidson et al.
patent: 4361549 (1982-11-01), Kung et al.
patent: 4444744 (1984-04-01), Goldenberg
patent: 4579827 (1986-04-01), Sakamoto et al.
patent: 4650756 (1987-03-01), Old et al.
patent: 4661347 (1987-04-01), Muller-Eberhard et al.
patent: 4661586 (1987-04-01), Leny et al.
patent: 4675287 (1987-06-01), Reisfeld et al.
patent: 4693966 (1987-09-01), Houghton et al.
patent: 4714613 (1987-12-01), Shouval et al.
patent: 4939240 (1990-07-01), Chu et al.
Young et al., Science, 211, 487-9 (1981).
Dippold et al., Conser. Res. 44(2) 1984 pp. 806-810.
Cheresh et al., PNAS 82(15) pp.5/55-5/59, 1985 (abst. CA).
Chany et al., CA vol. 103, 1985, #20951j.
Young et al., CA vol. 94, 1981, #101209W.
Ito et al., CA vol. 102, 1985, #76880y.
Katano, CA vol. 101, 1984, #189449.
Herlyn et al., Env. J. Immunol., 1979, 9, pp. 657-659.
Manson et al., Biochemica Biophysica Acta 1985, 834, pp. 110-116.
Nilsson et al., Biochimica Biophysica Acta 1985, pp. 577-583.
Lundholm et al., Int Archs Allergy Appl Immun 71, 1983, pp. 178-181.
Maymani et al., Science 212 1981 pp. 55-56.
Nakeinz, J. Leukoyta Biol., 35(1), 1984, pp. 131-139 (abst).
Imai et al., Scond. J Immunol 14(4), 1981, pp. 369-377 (abst).
Kawase et al., Conser Res 45(4), 1985, pp. 1663-1668 (abst).
Hellstrom et al., 1985, Proc. Natl. Acad. Sci. 82:1499-1502.
Hellstrom et al., 1985, Monoclonal Antibodies and Cancer Therapy, USCLA Symp. on Molec. and Cell. Biol., Alan R. Liss) pp. 149-164.
Hellstrom and Hellstrom in Accomplishments in Cancer Research 1985, 194:216-240 (J. F. Fortner, J. E. Rhoads, J. B. Lippincott. Co.).
Hellstrom et al., 1984, Contrib. to Oncol. Series: Genes and Antigens in Cancer Cells (Reithmuller, Koprowski, Van Kliest & Munk), pp. 121-131.
Burchell et al. in Monoclonal Antibodies for Tumor Detection and Drug Targeting (R. W. Baldwin & V. S. Byers, Acad. Press, 1985) pp. 1-15.
Hakomori, 1984, Ann. Rev. Immunol., 2:103-126.
Nepom, 1984, Proc. Natl. Acad. Sci., 81:2864-2867.
Koprowski et al., 1984, Proc. Natl. Acad. Sci., 81:216-219.
Hellstrom et al., 1983, J. Immunol., 130:1467-1472.
Nudelman et al., 1982, J. Biol. Chem., 257:12752-12756.
Brown et al., 1981, J. Immunol., 127:539-546.
Colcher et al., 1981, Cancer Res., 41:1451-1459.
Woodbury et al., 1980, Proc. Natl. Acad. Sci., 77:2183-2186.
Schulz et al., 1983, Proc. Natl. Acad. Sci., 80:5407-5411.
Fidler and Poste, 1982, Springer Semin. Immunopathol. 5:161-174.
Hellstrom et al., 1981, Int. J. Cancer, 27:281-285.
Uananue and Benacerraf, 1984, Text. Immunol. (Williams & Wilkins, Chapter (12)), pp. 218-238.
Cerrottini et al., 1974, Adv. Immunol., 18:67-132.
Julius et al., 1973, Eur. J. Immunol., 3:645-649.
Pollack et al., 1972, Int. J. Cancer, 9:316-323.
Skurzak et al., 1972, J. Exp. Med. 135:997-1102.
MacLennan et al., 1969, Immunol. 17:897-910.
Perlmann et al., 1969, Adv. Immunol. 11:117-193.
Hellstrom et al., 1965, Progr. Allergy 9:158-245.
Rowland et al., 1985, Cancer. Immunol. Immunother., 19:1-7.
DeNardo et al., 1985, Int. J. Radiation Oncology Biol. Phys., 11:335-348.
Kemshead in Monoclonal Antibodies for Tumor Detection and Drug Targeting (R. W. Baldwin & V. S. Byers, Academic Press, 1985) pp. 281-302.
Vitetta and Uhr, 1984, Transplant., 37:535-538.
Order, 1984, Comp. Ther. 10:9-18.
Carrasquillo et al., 1984, Cancer Treatment Reports, 68:317-328.
Larson et al., 1983, J. Clin. Invest. 72:2101-2114.
Yeh et al., 1982, Int. J. Cancer, 29:269-275.
Garrigues et al., 1982, Int. J. Cancer, 29:511-515.
Jansen et al., 1982, Immunol. Rev., 62:185-216.
Brown et al., 1981, Proc. Natl. Acad. Sci., 78:539-543.
Brown et al., 1979, J. Immunol. Meth., 31:201-209.
Hurwitz et al., 1975, Cancer Res., 35:1175-1181.
Ghose et al., 1972, Brit. Med. J., 3:495-499.
Cole et al., 1985, in Monoclonal Antibodies and Cancer Therapy (Alan R. Liss) pp. 77-96.
Takeda et al., 1985, Nature, 314:452-454.
Neuberger et al., 1984, Nature, 312:604-608.
Morrison et al., 1984, Proc. Natl. Acad. Sci., 81:6851-6855.
Cote et al., 1983, Proc. Natl. Acad. Sci., 80:2026-2030.
Ey et al., 1978, Immunochemistry, 15:429-436.
Kohler & Milstein, 1975, Nature, 256:495-497.ph 05091178

Affiliated with

Also associated with

Rating

Tumor therapy with biologically active anti-tumor antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumor therapy with biologically active anti-tumor antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor therapy with biologically active anti-tumor antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1891501